Effects of Aerobic Interval Training on Glucose Tolerance in Children and Adolescents With Cystic Fibrosis
Primary Purpose
Cystic Fibrosis
Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Educational intervention
Aerobic exercise
Sponsored by
About this trial
This is an interventional treatment trial for Cystic Fibrosis focused on measuring Cystic fibrosis, Insulin Resistance, Aerobic Exercise, Child, Adolescents
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of cystic fibrosis, according to the Brazilian Guidelines for diagnosis and treatment of CF;
- Prepubertal or pubertal, according to the Tanner scale
- Both sex.
Exclusion Criteria:
- Inability to perform the protocol established to the study;
- To be unable to understand and / or perform procedures.
- Exacerbation of the clinical picture, defined as modification and / or addition of antibiotic.
- To be pregnant.
Sites / Locations
- Karolinne Souza MonteiroRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
High Intensity Interval Training
Control Group
Arm Description
The subjects will participate of an educational intervention and a High Intensity Interval Training.
The subjects will participate of an educational intervention.
Outcomes
Primary Outcome Measures
Change in glucose tolerance
Glucose tolerance will be determined by measuring fasting Insulin, fasting glucose, OGTT for all patients.
Secondary Outcome Measures
Cystic fibrosis Quality of life
the Quality of Life Questionnaire in Cystic Fibrosis (QFC) was translated and validated into Portuguese in 2006. There are four versions of the questionnaire, according to age group: 6 to 11 years (35 questions), 12 and 13 years (35 questions), 14 years or more (50 questions) and parents of children between 6 and 11 years old (44 questions). For children between 6 and 11 years old the application of the questionnaire will be assisted by special cards that will designate the child's response. The questionnaire addresses the physical, body image, digestive, respiratory, emotional, social, nutrition, treatment, vitality, health, social role and weight domains. The scores of each domain range from zero to 100, considering a good quality of life if score above 50.
Lung Function
Forced expired volume in one second (FEV1) and forced vital capacity (FVC), FEV1/FVC ratio, forced expiratory flow at 25-75% of the pulmonary volume (FEF25-75).
Functional capacity
The 3 minute step test
Respiratory muscle strength
Maximum respiratory pressure
Exacerbations
Exacerbations of Cystic Fibrosis through the criteria of Fuchs
Full Information
NCT ID
NCT03653949
First Posted
August 14, 2018
Last Updated
October 1, 2019
Sponsor
Universidade Federal do Rio Grande do Norte
Collaborators
Universidade Estadual da Paraiba
1. Study Identification
Unique Protocol Identification Number
NCT03653949
Brief Title
Effects of Aerobic Interval Training on Glucose Tolerance in Children and Adolescents With Cystic Fibrosis
Official Title
Effects of Aerobic Interval Training on Glucose Tolerance in Children and Adolescents With Cystic Fibrosis: Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
October 2019
Overall Recruitment Status
Unknown status
Study Start Date
February 4, 2019 (Actual)
Primary Completion Date
December 2019 (Anticipated)
Study Completion Date
December 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidade Federal do Rio Grande do Norte
Collaborators
Universidade Estadual da Paraiba
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to investigate the effects of aerobic exercise on glucose tolerance in individuals with cystic fibrosis.
The hypothesis is that performing High Intensity Interval Training glucose tolerance will improve in individuals with cystic fibrosis.
Detailed Description
This is a controlled, randomized, and single blind trial. The first researcher (P1) will be responsible for the randomization process; the second researcher (P2) will be responsible for the evaluations and reevaluations. This evaluator (P2) will be "blind", meaning that for him it is totally unknown in which group each patient will be insert; and the third researcher (P3), will be responsible for statistical analysis.
Individuals will be recruited at the Child and Adolescent Health Care Unit of the Onofre Lopes University Hospital (HUOL) and in the Department of Physical Therapy of the State University of Paraíba (UEPB), Campina Grande - PB, Brazil. They will be evaluated at the Physical Therapy Department of the Federal University of Rio Grande do Norte (UFRN), Natal - RN, Brazil and in the Department of Physical Therapy of the State University of Paraíba (UEPB), in the city of Campina Grande - PB. A pilot study will be carried out and the sample calculation will be done with the data collected to reach a statistical power of 80% and a level of significance of 0.05%. Allocation in the groups will be performed by P1, randomly in blocks by the volunteer being prepubertal or pubertal. The R Core Team software (2015) will be used for this process.
In this study two groups will be considered: control group (CG) and aerobic exercise group (AEG). The CG will be submitted to educational intervention. The AEG will be submitted to the same educational intervention and to the High Intensity Interval Training.
After the pilot study, the patients will be evaluated to obtain information on severity and exacerbation of the disease, quality of life, metabolic evaluation, anthropometric measures, and lung function. All evaluations will be carried out at the same day period (morning). Researcher two (P2) will be responsible for the evaluation and reassessment procedure of the individuals, hence he will be "blind" meaning that for him it is totally unknown in which group each patient will be or was inserted. Individuals will be instructed to do not perform physical activity in the day before the evaluations. After this step, individuals will be randomly distributed in CG or EAG.
Volunteers from both groups will be instructed to maintain nutritional, drug and secretion care. In addition, they will be instructed to do not get engaged in any other kind of physical activity. The intervention will last 2 months and will occur 3 times a week until a total of 24 sessions. After the intervention ends and after the 8-week follow-up, all volunteers will be reevaluated.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cystic Fibrosis
Keywords
Cystic fibrosis, Insulin Resistance, Aerobic Exercise, Child, Adolescents
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Masking Description
Simple blind (investigador/outcomes aseessor)
Allocation
Randomized
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
High Intensity Interval Training
Arm Type
Experimental
Arm Description
The subjects will participate of an educational intervention and a High Intensity Interval Training.
Arm Title
Control Group
Arm Type
Active Comparator
Arm Description
The subjects will participate of an educational intervention.
Intervention Type
Other
Intervention Name(s)
Educational intervention
Intervention Description
It will be an interactive lecture, 60 minutes long. The class will cover physiopathology, complications, treatment and prevention of exacerbations. Audiovisual resources and practical demonstrations of usual care will be used. Individual questions will be answered during the class.
Intervention Type
Other
Intervention Name(s)
Aerobic exercise
Intervention Description
The aerobic exercise program will be performed at home, on a cycle ergometer for lower limbs between 24 and 35 minutes: 5 minutes of warm-up, 14 to 25 minutes of high-intensity interval exercise and 5 minutes of cool down.
Primary Outcome Measure Information:
Title
Change in glucose tolerance
Description
Glucose tolerance will be determined by measuring fasting Insulin, fasting glucose, OGTT for all patients.
Time Frame
Measured at baseline, after 8 and 16 weeks.
Secondary Outcome Measure Information:
Title
Cystic fibrosis Quality of life
Description
the Quality of Life Questionnaire in Cystic Fibrosis (QFC) was translated and validated into Portuguese in 2006. There are four versions of the questionnaire, according to age group: 6 to 11 years (35 questions), 12 and 13 years (35 questions), 14 years or more (50 questions) and parents of children between 6 and 11 years old (44 questions). For children between 6 and 11 years old the application of the questionnaire will be assisted by special cards that will designate the child's response. The questionnaire addresses the physical, body image, digestive, respiratory, emotional, social, nutrition, treatment, vitality, health, social role and weight domains. The scores of each domain range from zero to 100, considering a good quality of life if score above 50.
Time Frame
Measured at baseline, after 8 and 16 weeks.
Title
Lung Function
Description
Forced expired volume in one second (FEV1) and forced vital capacity (FVC), FEV1/FVC ratio, forced expiratory flow at 25-75% of the pulmonary volume (FEF25-75).
Time Frame
Measured at baseline, after 8 and 16 weeks.
Title
Functional capacity
Description
The 3 minute step test
Time Frame
Measured at baseline, after 8 and 16 weeks.
Title
Respiratory muscle strength
Description
Maximum respiratory pressure
Time Frame
Measured at baseline, after 8 and 16 weeks.
Title
Exacerbations
Description
Exacerbations of Cystic Fibrosis through the criteria of Fuchs
Time Frame
Measured at baseline, after 8 and 16 weeks.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnosis of cystic fibrosis, according to the Brazilian Guidelines for diagnosis and treatment of CF;
Prepubertal or pubertal, according to the Tanner scale
Both sex.
Exclusion Criteria:
Inability to perform the protocol established to the study;
To be unable to understand and / or perform procedures.
Exacerbation of the clinical picture, defined as modification and / or addition of antibiotic.
To be pregnant.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Karolinne Monteiro, Master
Phone
+5584996387722
Email
karolsm@outlook.com.br
First Name & Middle Initial & Last Name or Official Title & Degree
Thayla Santino, Master
Phone
+5583999424386
Email
thaylaamorim@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karolinne Monteiro, Master
Organizational Affiliation
Universidade Federal do Rio Grande do Norte
Official's Role
Principal Investigator
Facility Information:
Facility Name
Karolinne Souza Monteiro
City
Natal
State/Province
RN
ZIP/Postal Code
59064-741
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Karolinne S Monteiro, Master
Phone
5583996387722
Email
karolsm@outlook.com.br
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
31878961
Citation
Monteiro KS, Azevedo MP, Jales LM, da Silva FEP, Arrais RF, de Mendonca KMPP. Effects of aerobic interval training on glucose tolerance in children and adolescents with cystic fibrosis: a randomized trial protocol. Trials. 2019 Dec 26;20(1):768. doi: 10.1186/s13063-019-3803-8.
Results Reference
derived
Learn more about this trial
Effects of Aerobic Interval Training on Glucose Tolerance in Children and Adolescents With Cystic Fibrosis
We'll reach out to this number within 24 hrs